Phatchanat Klaihmon received his Ph.D. (Immunology) from Mahidol University under the supervision of Prof. Dr. Kovit Pattananpanyasat in 2016. During graduate period, he have developed flow cytometry-based assays to characterize and study the biological effects of cell-derived extracellular vesicles (EVs) in the context of pathogenesis of thromboembolic events commonly  found in hematologic disorders. He was also granted to join Prof. Dr. Chantal Boulanger’s laboratory in Paris Cardiovascular Research Center as a visiting trainee in order to track his interest in EVs and cardiovascular disease. In late 2017, he took part in SiSCR as postdoctoral research assistant and is in charge of flow cytometry and cell sorter platform. Currently, his researches include signaling pathways associated with hematologic disease, particularly leukemia, and development of cell-based immunotherapy.

CV

e-mail: phatchanat.kla@mahidol.ac.th

Publication:

  1. Lorthongpanich C, Jiamvoraphong1 N, Supraditaporn K, Klaihmon P, U-pratya Y and Issaragrisil S, The Hippo pathway regulates human megakaryocytic differentiation. Thromb Haemost, 2017 Jan 5; 117(1): 116-126.
  2. Klaihmon P, Phongphao K, Kheansaard W, Noulsri E, Khuhapinant A, Fucharoen S, Morales NP, Svasti S, Pattanapanyasat K, Chaichompoo P, Microparticles from splenectomized β-thalassemia/HbE patients play roles on procoagulant activities with thrombotic potential. Ann Hematol, 2017 Feb; 96(2): 189-198.
  3. Klaihmon P, Vimonpatranon S, Noulsri E, Lertthammakiat S, Anurathapan U, Sirachainan N, Hongeng S, Pattanapanyasat K, Normalized levels of red blood cells expressing phosphatidylserine, their microparticles, and activated platelets in young patients with β-thalassemia following bone marrow transplantation. Ann Hematol, 2017 Oct; 96(10): 1741-1747.
  4. Loyer X, Zlatanova I, Devue C, Yin M, Howangyin KY, Klaihmon P, Guerin CL, Kheloufi M, Vilar J, Zannis K, Fleischmann BK, Hwang DW, Park J, Lee H, Menasche P, Silvestre JS, Boulanger CM. Intra-cardiac release of extracellular vesicles shapes inflammation following myocardial infarction. Cir Res, 2018 Jun; 123(1): 100-106.
  5. Klaihmon P, Lertthammakiat S, Anurathapan U, Pakakasama S, Sirachainan N, Hongeng S, Pattanapanyasat K, Activated platelets and leukocyte activations in young patients with β-thalassemia/HbE following bone marrow transplantation. Thromb Res, 2018 Sep; 169: 8-14.
  6. Luanpitpong S, Janan M, Thumanu K, Poohadsuan J, Rodboon N, Klaihmon P, Issaragrisil S. Deciphering the elevated lipid via CD36 in mantle cell lymphoma with bortezomib resistance using synchrotron-based fourier transform infrared spectroscopy of single cells. Cancers (Basel). 2019 Apr 24;11(4):576.
  7. Lorthongpanich C, Laowtammathron C, Jiamvoraphong N, Srisook P, Chingsuwanrote P, Klaihmon P, Damkham N, Terbto P, Waeteekul S, U-Pratya Y, Issaragrisil S. YAP-depleted iPSC MUSIi012-A-2 maintained all normal stem cell characteristics. Stem Cell Res. 2020 Mar;4 3:101723.


Phatchanat Klaihmon received his Ph.D. (Immunology) from Mahidol University under the supervision of Prof. Dr. Kovit Pattananpanyasat in 2016. During graduate period, he have developed flow cytometry-based assays to characterize and study the biological effects of cell-derived extracellular vesicles (EVs) in the context of pathogenesis of thromboembolic events commonly  found in hematologic disorders. He was also granted to join Prof. Dr. Chantal Boulanger’s laboratory in Paris Cardiovascular Research Center as a visiting trainee in order to track his interest in EVs and cardiovascular disease. In late 2017, he took part in SiSCR as postdoctoral research assistant and is in charge of flow cytometry and cell sorter platform. Currently, his researches include signaling pathways associated with hematologic disease, particularly leukemia, and development of cell-based immunotherapy.

CV

e-mail: phatchanat.kla@mahidol.ac.th

Publication:

  1. Lorthongpanich C, Jiamvoraphong1 N, Supraditaporn K, Klaihmon P, U-pratya Y and Issaragrisil S, The Hippo pathway regulates human megakaryocytic differentiation. Thromb Haemost, 2017 Jan 5; 117(1): 116-126.
  2. Klaihmon P, Phongphao K, Kheansaard W, Noulsri E, Khuhapinant A, Fucharoen S, Morales NP, Svasti S, Pattanapanyasat K, Chaichompoo P, Microparticles from splenectomized β-thalassemia/HbE patients play roles on procoagulant activities with thrombotic potential. Ann Hematol, 2017 Feb; 96(2): 189-198.
  3. Klaihmon P, Vimonpatranon S, Noulsri E, Lertthammakiat S, Anurathapan U, Sirachainan N, Hongeng S, Pattanapanyasat K, Normalized levels of red blood cells expressing phosphatidylserine, their microparticles, and activated platelets in young patients with β-thalassemia following bone marrow transplantation. Ann Hematol, 2017 Oct; 96(10): 1741-1747.
  4. Loyer X, Zlatanova I, Devue C, Yin M, Howangyin KY, Klaihmon P, Guerin CL, Kheloufi M, Vilar J, Zannis K, Fleischmann BK, Hwang DW, Park J, Lee H, Menasche P, Silvestre JS, Boulanger CM. Intra-cardiac release of extracellular vesicles shapes inflammation following myocardial infarction. Cir Res, 2018 Jun; 123(1): 100-106.
  5. Klaihmon P, Lertthammakiat S, Anurathapan U, Pakakasama S, Sirachainan N, Hongeng S, Pattanapanyasat K, Activated platelets and leukocyte activations in young patients with β-thalassemia/HbE following bone marrow transplantation. Thromb Res, 2018 Sep; 169: 8-14.
  6. Luanpitpong S, Janan M, Thumanu K, Poohadsuan J, Rodboon N, Klaihmon P, Issaragrisil S. Deciphering the elevated lipid via CD36 in mantle cell lymphoma with bortezomib resistance using synchrotron-based fourier transform infrared spectroscopy of single cells. Cancers (Basel). 2019 Apr 24;11(4):576.
  7. Lorthongpanich C, Laowtammathron C, Jiamvoraphong N, Srisook P, Chingsuwanrote P, Klaihmon P, Damkham N, Terbto P, Waeteekul S, U-Pratya Y, Issaragrisil S. YAP-depleted iPSC MUSIi012-A-2 maintained all normal stem cell characteristics. Stem Cell Res. 2020 Mar;4 3:101723.